trending Market Intelligence /marketintelligence/en/news-insights/trending/y4zzj7tbyxti-mua2dlbrg2 content esgSubNav
In This List

ImmunoPrecise to buy 2 Dutch companies in €7M deal

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ImmunoPrecise to buy 2 Dutch companies in €7M deal

ImmunoPrecise Antibodies Ltd. is buying two Dutch companies ModiQuest Research BV and Immulease BV — for €7 million.

The Victoria, British Columbia-based company will pay €5 million at the time of closing, comprising €2.5 million in cash and 6,600,399 shares.

The remaining €2 million will be paid as deferred payments over the course of three years in three equal installments of cash and equity totaling €666,666.

ImmunoPrecise plans to finance the transaction by completing a debenture financing in the amount of up to C$4.1 million.

ModiQuest is focused on therapeutic antibody discovery, while Immulease works on medical research equipment.